logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10946069 B1

PDFFull Text
Date of Patent:
Mar. 16, 2021

Filed:

May. 02, 2019

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

Applicants:

Astellas Pharma Inc., Tokyo, JP;

Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz Gemeinnutzige Gmbh, Mainz, DE;

Inventors:

Ugur Sahin, Mainz, DE;

Ozlem Tureci, Mainz, DE;

Rita Mitnacht-Kraus, Friedberg, DE;

Stefan Woll, Nackenheim, DE;

Stefan Jacobs, Mainz-Kastel, DE;

Cornelia Heinz, Dalheim, DE;

Assignees:

Astellas Pharma Inc., Tokyo, JP;

TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz, DE;

Attorneys:

Neal, Gerber & Eisenberg LLP

Kevin A. O'Connor

Primary Examiner:

Elly-Gerald Stoica

Int. Cl.
CPC ...
C07K 16/28 (2006.01); C07K 16/30 (2006.01); A61K 31/7068 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01); A61K 38/20 (2006.01); A61K 39/395 (2006.01); A61K 31/555 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2013 (2013.01); A61K 31/555 (2013.01); A61K 31/7068 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 16/303 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/34 (2013.01); C07K 2317/73 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/74 (2013.01);
Abstract

The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.

Find Patent Forward Citations

Sahin, Ugur. (2021). Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer (U.S. Patent No. 10946069). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10946069

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…